GlassScriptPhysician profile
Vincent M Perino
NPI 1598189714
$2,492.51
in general payments reported to CMS, 2019-2025
20 companies · $30.86 in 2025
The $30.86 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $680 · 2023: $1,000 · 2024: $423 · 2025: $30.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $544.75 | 2021-2024 | |
| Boston Scientific Corporation | $434.14 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $386.80 | 2021-2024 | Relistor |
| Nevro Corp. | $300.36 | 2022-2024 | Senza |
| Vertos Medical, INC. | $187.45 | 2023-2024 | Mild Device Kit |
| Medtronic, INC. | $125.65 | 2022 | |
| Pfizer INC. | $106.54 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $77.59 | 2023-2024 | Belbuca, Xtampza |
| Biohaven Pharmaceutical Holding Company LTD. | $76.20 | 2022 | |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Pacira Therapeutics, INC. | $41.18 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $26.31 | 2023 | Zilretta |
| Arbor Pharmaceuticals, INC. | $22.55 | 2021 | |
| Azurity Pharmaceuticals, INC. | $20.65 | 2023 | Horizant |
| Tactile Systems Technology INC | $19.83 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.67 | 2021 | |
| Painteq LLC | $19.54 | 2024 | Painteq |
| Inspire Medical Systems, INC. | $13.93 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $12.31 | 2022 | |
| Eisai INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Perino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.